Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging

RS Negrin(Stanford University), ML Cleary(Stanford Medicine), IG Schmidt-Wolf(Stanford University), KG Blume(Stanford University), HP Kiem(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Blood
February 1, 1991
10.1182/blood.v77.3.654.654
Cited by 70

Related Papers

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
|The Journal of Experimental Medicine|1991|623
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy
|Blood|1993|284
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy
|Blood|1996|209
Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector
|Blood|1994|128
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells
|Blood|1995|127